DYNE THERAPEUTICS INC (DYN:NASDAQ)
$23.74 1.02 (4.4894%)
Analysed DYNE THERAPEUTICS INC (DYN:NASDAQ) News Sources
A Look At Dyne Therapeutics (DYN) Valuation After Key ACHIEVE Trial Enrollment Milestone
05-06-2026
yahoo.com
Dyne Therapeutics (DYN) Reaches Key Regulatory Milestone
05-06-2026
yahoo.com
Dyne Therapeutics (DYN) Concludes Phase 1/2 ACHIEVE Trial Enrollment
11-06-2026
yahoo.com
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.
17-06-2026
yahoo.com
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18-06-2026
yahoo.com
Dyne Therapeutics Appoints Barry Greene to Board of Directors
22-06-2026
yahoo.com
Dyne Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
26-06-2026
fool.com
Dyne Therapeutics vs. Vertex Pharmaceuticals: Which Drug Innovator Stock Is a Better Buy in 2026?
01-07-2026
fool.com
Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026?
04-07-2026
fool.com
Dyne Therapeutics (DYN) Inspires Confidence With Its Force Platform
15-07-2026
yahoo.com
What is the current price of DYNE THERAPEUTICS INC (DYN:NASDAQ)?
The current price of DYNE THERAPEUTICS INC (DYN:NASDAQ) is $23.74.
DYNE THERAPEUTICS INC (DYN:NASDAQ) absolute price change since previous trading day?
The absolute price change of DYNE THERAPEUTICS INC (DYN:NASDAQ) since the previous trading day is $1.02.
DYNE THERAPEUTICS INC (DYN:NASDAQ) percentage price change since previous trading day?
The percentage price change of DYNE THERAPEUTICS INC (DYN:NASDAQ) since the previous trading day is 4.4894%.
What is the most recent average sentiment score for DYNE THERAPEUTICS INC (DYN:NASDAQ)?
The most recent average sentiment score for DYNE THERAPEUTICS INC (DYN:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for DYNE THERAPEUTICS INC (DYN:NASDAQ)?
The most recent sentiment for DYNE THERAPEUTICS INC (DYN:NASDAQ) is .
SEC-8K** Filing Available For DYNE THERAPEUTICS INC (DYN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.